Menopause and Common Inflammatory Dermatoses: Current Evidence and Clinical Implications

Menopause is a natural biological transition characterised by declining oestrogen levels, with significant effects on skin structure, barrier function, and inflammation. While these physiological changes are well recognised, the impact of menopause on common inflammatory dermatoses remains poorly understood. This review examines the current evidence on acne, rosacea, hidradenitis suppurativa, psoriasis, lichen sclerosus, and lichen planus in peri- and postmenopausal women, focusing on clinical presentation and management. The relationship between menopause and individual inflammatory dermatoses is complex, with considerable variation in disease presentation and response to hormonal treatment. In particular, the role of hormone replacement therapy remains uncertain. Management should therefore continue to follow established disease-specific guidelines, while taking into account menopausal symptoms, hormonal treatments, skin sensitivity and associated comorbidities. Further prospective studies incorporating hormonal measurements, molecular markers, and treatment responses are needed to better understand the relationship between menopause and inflammatory skin disease and develop evidence-based management strategies for women during and after the menopausal transition.

Authors

Institutions

Publication Details

Journal
EMJ Dermatology
Published
2026-11-12
DOI
https://doi.org/10.33590/emjdermatol/64n20m4f
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Menopause and Common Inflammatory Dermatoses: Current Evidence and Clinical Implications

Irfana Pharveen, Claudia DeGiovanni
EMJ Dermatology
Menopause: Health Impacts and Treatments
article

Menopause and Common Inflammatory Dermatoses: Current Evidence and Clinical Implications

Irfana Pharveen, Claudia DeGiovanni
article en

Abstract

Menopause is a natural biological transition characterised by declining oestrogen levels, with significant effects on skin structure, barrier function, and inflammation. While these physiological changes are well recognised, the impact of menopause on common inflammatory dermatoses remains poorly understood. This review examines the current evidence on acne, rosacea, hidradenitis suppurativa, psoriasis, lichen sclerosus, and lichen planus in peri- and postmenopausal women, focusing on clinical presentation and management. The relationship between menopause and individual inflammatory dermatoses is complex, with considerable variation in disease presentation and response to hormonal treatment. In particular, the role of hormone replacement therapy remains uncertain. Management should therefore continue to follow established disease-specific guidelines, while taking into account menopausal symptoms, hormonal treatments, skin sensitivity and associated comorbidities. Further prospective studies incorporating hormonal measurements, molecular markers, and treatment responses are needed to better understand the relationship between menopause and inflammatory skin disease and develop evidence-based management strategies for women during and after the menopausal transition.

EMJ Dermatology
University Hospitals Sussex NHS Foundation Trust (GB)
Good health and well-being
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon